Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathological Characteristics and Prognosis of Remnant Gastric Cancer

  • Lee, Sang-Bong (Department of Surgery, Pusan National University and School of Medicine) ;
  • Kim, Jae-Hun (Department of Surgery, Pusan National University and School of Medicine) ;
  • Kim, Dae-wan (Department of Surgery, Pusan National University and School of Medicine) ;
  • Jeon, Tae-Yong (Department of Surgery, Pusan National University and School of Medicine) ;
  • Kim, Dong-Heon (Department of Surgery, Pusan National University and School of Medicine) ;
  • Kim, Gwang-Ha (Department of Internal Medicine, Pusan National University and School of Medicine) ;
  • Park, Do-Youn (Department of Pathology, Pusan National University and School of Medicine)
  • Received : 2010.08.27
  • Accepted : 2010.10.14
  • Published : 2010.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The long-term survival rate of gastric cancer patients after surgery has recently increased as a result of making an early diagnosis of gastric cancer. Therefore, the incidence of remnant gastric cancer is increasing. This study was performed to evaluate the clinicopathological characteristics and prognosis of patients with remnant gastric cancer. Materials and Methods: From January 2005 to December 2009, twenty-nine patients with remnant gastric cancer and who underwent surgery at Pusan National University Hospital were enrolled in this study. We retrospectively reviewed and analyzed their medical records. We also divided them into two groups: the remnant gastric cancer (RGC)-B group (first operation for benign disease) and the RGC-M group (first operation for malignant disease). Results: The RGC-B group included ten patients and the RGC-M group included nineteen patients. The mean interval between the first and second operations was 17 years. The curative resection rate was 93.1% (27/29). The postoperative complication rate was 20.7% (6/29) and there was no perioperative mortality. Ten (37%) of twenty-seven patients experienced recurrence after curative resection and eight patients (27.6%) expired due to aggravation of remnant stomach cancer. An advanced TNM stage and non-curative resection were the negative prognostic factors for survival for patients with remnant stomach cancer (P=0.0453 and P<0.001). The RGC-M group showed a shorter interval (P<0.001) and the RGC-B group had more advanced TNM stage (P=0.003). Conclusions: Long-term follow-up should be considered not only for patients who undergo an operation for malignant disease, but also for the patients who underwent an operation for benign disease. When remnant gastric cancer is diagnosed, curative resection is essential to improve the survival.

Keywords

References

  1. Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg 2007;94:92-95. https://doi.org/10.1002/bjs.5538
  2. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions. J Am Coll Surg 1996;182:1-6.
  3. Kaneko K, Kondo H, Saito D, Shirao K, Yamaguchi H, Yokota T, et al. Early gastric stump cancer following distal gastrectomy. Gut 1998;43:342-344. https://doi.org/10.1136/gut.43.3.342
  4. Firat O, Guler A, Sozbilen M, Ersin S, Kaplan H. Gastric remnant cancer: an old problem with novel concerns. Langenbecks Arch Surg 2009;394:93-97. https://doi.org/10.1007/s00423-008-0382-7
  5. Hu X, Tian DY, Cao L, Yu Y. Progression and prognosis of gastric stump cancer. J Surg Oncol 2009;100:472-476. https://doi.org/10.1002/jso.21370
  6. Ahn HS, Kim JW, Yoo MW, Park do J, Lee HJ, Lee KU, et al. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol 2008;15:1632-1639. https://doi.org/10.1245/s10434-008-9871-8
  7. Th orban S, Böttcher K, Etter M, Roder JD, Busch R, Siewert JR. Prognostic factors in gastric stump carcinoma. Ann Surg 2000;231:188-194. https://doi.org/10.1097/00000658-200002000-00006
  8. Lissens P, Filez L, Aerts R, D'Hoore A, Van Cutsem E, Ectors N, et al. Surgery for gastric remnant carcinoma following Billroth II gastrectomy. Eur J Surg Oncol 1997;23:518-521. https://doi.org/10.1016/S0748-7983(97)93013-4
  9. An JY, Youn HG, Ha TK, Choi MG, Kim KM, Noh JH, et al. Clinical significance of tumor location in remnant gastric cancers developed aft er partial gastrectomy for primary gastric cancer. J Gastrointest Surg 2008;12:689-694. https://doi.org/10.1007/s11605-007-0437-z
  10. Sinning C, Schaefer N, Standop J, Hirner A, Wolff M. Gastric stump carcinoma - epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol 2007;33:133-139. https://doi.org/10.1016/j.ejso.2006.09.006
  11. Furukawa H, Iwanaga T, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, et al. Gastric remnant cancer as a metachronous multiple lesion. Br J Surg 1993;80:54-56. https://doi.org/10.1002/bjs.1800800120
  12. Kaminishi M, Shimizu N, Yamaguchi H, Hashimoto M, Sakai S, Oohara T. Diff erent carcinogenesis in the gastric remnant after gastrectomy for gastric cancer. Cancer 1996;77(8 Suppl): 1646-1653. https://doi.org/10.1002/(SICI)1097-0142(19960415)77:8<1646::AID-CNCR34>3.0.CO;2-Y
  13. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer 2002;5:177-182. https://doi.org/10.1007/s101200200031
  14. Zhang Y, Tokunaga A, Masuda G, Okuda T, Kiyama T, Yoshiyuki T, et al. Surgical treatment of gastric remnant-stump cancer. J Nippon Med Sch 2002;69:489-493. https://doi.org/10.1272/jnms.69.489
  15. Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, et al. Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy. J Gastrointest Surg 2010;14:277-281. https://doi.org/10.1007/s11605-009-1090-5

Cited by

  1. Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China vol.7, pp.11, 2010, https://doi.org/10.1371/journal.pone.0050084
  2. A New Early Gastric Cancer after Subtotal Gastric Resection for Early Cancer: Case Report and Review of the Literature vol.5, pp.14, 2010, https://doi.org/10.4236/jct.2014.514146
  3. Prognostic Value of Tumor Size in Patients with Remnant Gastric Cancer: Is the Seventh UICC Stage Sufficient for Predicting Prognosis? vol.9, pp.12, 2010, https://doi.org/10.1371/journal.pone.0115776
  4. Gastric remnant cancer: A distinct entity or simply another proximal gastric cancer? vol.112, pp.8, 2015, https://doi.org/10.1002/jso.24080
  5. Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association vol.19, pp.2, 2010, https://doi.org/10.1007/s10120-015-0582-0
  6. Perforated Carcinoma in the Gastric Remnant: A Case of Conservative Treatment Prior to Successful Curative R0 Resection vol.2016, pp.None, 2010, https://doi.org/10.1155/2016/4091952
  7. Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer vol.37, pp.7, 2010, https://doi.org/10.1007/s13277-015-4368-0
  8. Clinicopathologic characteristics and prognosis of remnant gastric cancer vol.13, pp.2, 2017, https://doi.org/10.14216/kjco.17012
  9. Lower rate of conversion using robotic-assisted surgery compared to laparoscopy in completion total gastrectomy for remnant gastric cancer vol.34, pp.2, 2010, https://doi.org/10.1007/s00464-019-06838-3
  10. Management of Acute Gastric Remnant Complications After Roux-en-Y Gastric Bypass: a Single-Center Case Series vol.30, pp.7, 2010, https://doi.org/10.1007/s11695-020-04537-w